ATRC (AtriCure) Quality Rank


ATRC AtriCure Inc ATRC
76 GF Score
Price $31.80
GF Value $39.82
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is AtriCure Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

AtriCure Quality Rank Related Terms

ATRC
76GF Score
AtriCure Inc ATRC
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AtriCure (ATRC) Overvalued in 2026?

Based on GuruFocus' analysis, AtriCure stock appears to be undervalued. The current stock price of $31.80 is trading 20.1% below its estimated GF Value™ of $39.82. GuruFocus considers AtriCure to be Modestly Undervalued.

Key valuation signals for ATRC:

  • Quality Rank:
  • GF Value™: $39.82 vs. price of $31.80 (20.1% below fair value)
  • GF Score™: 76/100 with 1 warning sign

No single metric tells the full story. See the ATRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AtriCure Business Description

Address 7555 Innovation Way, Mason, OH, USA, 45040
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
76GF Score

Get the complete analysis for ATRC

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.80
Price
$39.82
GF Value